Diabetes treatment: The researchers said while the study was a rigorous one, based on high quality data from a large representative cohort,...

India sees a significant rise in overweight and obese populations recently. Rural areas show a particularly sharp increase in these health ...

In celebration of International Youth Day, we acknowledge the significant role played by young individuals in society, alongside their heal...

The Delhi High Court has directed Sun Pharma Laboratories to seek its approval before launching semaglutide tablets, following Novo Nordisk...

A parliamentary committee proposes mandatory kidney function tests for adults aged twenty and above. High-risk individuals will undergo ann...

Britain has become the first country in Europe to approve orforglipron, the oral weight loss and diabetes treatment developed by US company...

Britain's regulator approved Eli Lilly's Foundayo pill for weight and diabetes. This treatment is not yet available through the NHS in the ...

For Indian pharma, the regulatory risk is still real. A US FDA inspection can still cause trouble. A plant making an important product or g...

A word of caution for all those who have exposure to mid cap stocks or are planning to increase it. Just keep one thing in mind: If there i...

Novo Nordisk CEO Mike Doustdar said the company will speed up research and pursue smaller acquisitions to strengthen its drug pipeline afte...

Pfizer has reported impressive second-quarter earnings, driven by the success of Eliquis and newly acquired pharmaceutical products. The co...

Central government directs state regulators to enhance surveillance over GLP-1 drug promotion. Approved GLP-1 drugs are only for Type 2 dia...

Diabetes: Recent studies reveal that metformin may influence blood sugar management via the brain. This medication stimulates a distinct br...

Metformin may have been part of diabetes medicine for generations, but scientists are still uncovering new chapters in its story. The possi...

Many consumers using weight-loss drugs are now shopping more in physical stores. Sizing changes prompt shoppers to try on clothes, increasi...

Dermatologists report increased hair loss among GLP-1 drug users experiencing rapid weight reduction. This side effect, often telogen efflu...

Novo Nordisk is seeking a court injunction to stop Eli Lilly's drug advertisements. The Danish company claims Lilly's ads mislead consumers...